Meanwhile, treatment of colon cancer cells with curcumin or dasatinib induced significant reduction of p-EGFR while combination treatment led to much greater reduction of both p-EGFR and p-IGF-1R (Nautiyal et al., 2011). This evidence concerns the gene IGF1R and colonic neoplasm.